The use of short-echo-time 1H MRS for childhood cerebellar tumours prior to histopathological diagnosis

Pediatric Radiology

Volumn 37, Issue 11, 2007, Pages 1101-1109

  Harris, Lisa M ^a   Davies, Nigel ^a,b   MacPherson, Lesley ^c   Foster, Katharine ^c   Lateef, Shaheen ^c   Natarajan, Kal ^a,b   Sgouros, Spyridon ^c   Brundler, Marie Anne ^c   Arvanitis, Theodoros N ^a   Grundy, Richard G ^d   Peet, Andrew C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Analysis; Cerebellar tumours; Characterisation; Children; Diagnosis; MRS

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ARTICLE; CEREBELLUM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; ROC CURVE; SHORT ECHO TIME MAGNETIC RESONANCE SPECTROSCOPY; SPECTROSCOPY;

ASPARTIC ACID; CEREBELLAR NEOPLASMS; CEREBELLUM; CHILD; CHOLINE; CREATINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TUMOR MARKERS, BIOLOGICAL;

EID: 35248839535     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-007-0571-5     Document Type: Article

References (36)

1. Muckherji SK (ed) (1998) Clinical applications of MR spectroscopy. Wiley-Liss, New York
2. Preul MC, Caramanos Z, Collins DL et al (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325
3. Howe FA, Opstad KS (2003) 1H MR spectroscopy of brain tumours and masses. NMR Biomed 16:123-131
4. Tate AR, Underwood J, Acosta DM et al (2006) Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 19:411-434
5. Tong Z, Yamaki T, Harada K et al (2004) In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 22:1017-1024
6. Devos A, Lukas L, Suykens JA et al (2004) Classification of brain tumours using short echo time 1H MR spectra. J Magn Reson 170:164-175
7. Gajewicz W, Papierz W, Szymczak W et al (2003) The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes. Med Sci Monit 9:97-105
8. Hollingworth W, Medina LS, Lenkinski et al (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR 27:1404-1411
9. Wang Z, Sutton LN, Cnaan A et al (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR 16:1821-1833
10. Hourani R, Horska A, Albayram S et al (2006) Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging 23:99-107
11. Panigrahy A, Krieger MD, Gonzalez-Gomez I et al (2006) Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR 27:560-572
12. Vaidya SJ, Payne GS, Leach MO et al (2003) Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. Eur J Cancer 39:728-735
13. Warren KE (2004) NMR spectroscopy and paediatric brain tumours. Oncologist 9:312-318
14. Warren KE, Frank JA, Black JL et al (2000) Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumours. J Clin Oncol 18:1020-1026
15. Tzika AA, Astrakas LG, Zarifi MK et al (2004) Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumours. Cancer 100:1246-1256
16. Preul MC, Caramanos Z, Leblanc R et al (1998) Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 11:192-200
17. Nelson SJ (2003) Multivoxel magnetic resonance spectroscopy of brain tumours (review). Mol Cancer Ther 2:497-507
18. Laprie A, Pirzkall A, Haas-Kogan DA et al (2005) Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62:20-31
19. Lin A, Bluml S, Mamelak AN (1999) Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumours. J Neurooncol 45:69-81
20. Tarnawski R, Sokol M, Pieniazek P et al (2002) 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 52:1271-1276
21. Lin A, Ross BD, Harris K et al (2005) Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2:197-214
22. Preul MC, Caramanos Z, Villemure JG et al (2000) Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Neurosurgery 46:306-318
23. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
24. el-Deredy W (1997) Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review. NMR Biomed 10:99-124
25. Lisboa PJ, Kirby SP, Vellido A et al (1998) Assessment and neural networks methods in NMR spectral classification and metabolite selection. NMR Biomed 11:225-234
26. Tate AR, Majós C, Moreno A et al (2003) Automated classification of short echo time in vivo 1H brain tumor spectra: a multicenter study. Magn Reson Med 49:29-36
27. Naressi A, Couturier C, Castang I et al (2001) Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31:269-286
28. Pizzo PA, Poplack DG (eds) (2001) Principles and practice of pediatric oncology, 4th edn. Lippincott Williams and Wilkins, Philadelphia
29. Peet AC, Lateef S, MacPherson L et al (2007) Short echo time 1H magnetic resonance spectroscopy of childhood brain tumours. Childs Nerv Syst 23:163-169
30. Clementi V, Tonon C, Lodi R et al (2005) Assessment of glutamate and glutamine contribution to in vivo N-acetylaspartate quantification in human brain by 1H-magnetic resonance spectroscopy. Magn Reson Med 54:1333-1339
31. Kovanlikaya A, Panigrahy A, Krieger MD et al (2005) Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology 236:1020-1025
32. Peet A, Garala P, MacPherson L et al (2004) Mobile lipids detected by short echo time 1H magnetic resonance spectroscopy correlate with malignancy in childhood brain tumours. Neurooncology 6:471
33. Astrakas LG, Zurakowski D, Tzika AA et al (2004) Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10:8220-8228
34. Peet AC, Davies NP, Ridley L et al (2007) Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma. Eur J Cancer 43:1037-1044
35. Kreis R (2004) Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 17:361-381
36. Albers MJ, Krieger MD, Gonzalez-Gomez I et al (2005) Proton-decoupled 31P MRS in untreated pediatric brain tumors. Magn Reson Med 53:22-29